News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA)'s Stem Cell Technology Acquired by Novartis Corporation (NVS) (JOBS) in $50 Million Deal


8/7/2009 6:26:17 AM

Bookmark and Share

Reuters -- Opexa Therapeutics Inc said Swiss drug-maker Novartis has acquired its stem cell technology, which was in early preclinical development, sending its shares up 70 percent before the bell.

Read at Reuters
Read at Business Wire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES